We connect pharmaceutical sponsors and CROs with qualified investigator sites across Australia, covering Phase I first-in-human studies through to Phase IV post-market research.
Whether you are bringing a compound to Australia or running a clinic that wants to participate in research, we have a pathway for you.
Access a network of qualified Australian investigator sites, pre-screened patient populations, and an experienced coordination team. We handle the site side so your team can focus on the science.
Explore sponsor servicesTurn your existing clinical infrastructure into a revenue-generating research site. We provide the regulatory framework, training, coordination, and sponsor introductions your practice needs to participate safely.
Become a siteAccess clinical trials that may be appropriate for your situation. All trials conducted through our network meet Australian ethics and regulatory standards, and your treating clinician remains central to your care.
Learn about participationAustralian Clinical Trials was built by people who have spent careers inside clinical research. We have worked as site-level investigators, navigated sponsor requirements firsthand, and understand what monitors and auditors look for when they arrive at a site.
Every process we have built, every document standard we apply, and every site we bring into the network reflects that direct experience. This is not a technology platform trying to disrupt clinical trials. It is a professionally run research organisation that takes compliance as seriously as the sponsors and regulators who depend on it.
More about usTGA CTN pathway, HREC Single Ethical Review, ICH-GCP E6 R2, built into every activation from day one.
By using existing GP and community clinics, we bring trials closer to patients, reducing travel burden and broadening recruitment reach.
Formal SOPs, trained site staff, documented quality processes, so sponsors know what to expect before the first monitor visit.
A structured, four-stage process that gives sponsors confidence and gives sites clarity.
We review your protocol against our network's patient populations, therapeutic expertise, and site capabilities before committing.
Sites are selected, trained, and activated to your requirements, including SIV, delegation logs, and all regulatory submissions.
Our coordination team manages enrolment against your targets. Regular monitoring visits and data quality reviews run throughout.
Site closeout, essential document archiving, and final reporting completed to ICH-GCP and sponsor requirements.
Our network spans primary care and specialist settings, giving us access to patient populations across a broad range of therapeutic areas.
Including type 2 diabetes, hypertension, dyslipidaemia, and heart failure. Well-represented across GP clinic populations.
Depression, anxiety, migraine, and early-stage neurodegenerative disease. Access to community-based referral pathways.
Asthma, COPD, allergic rhinitis, and emerging biologics for inflammatory respiratory disease.
Send us a feasibility enquiry and we will respond within two business days.